Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:78-83

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henrion, D.
Right arrow Articles by Laher, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henrion, D.
Right arrow Articles by Laher, I.

Hypertension, Vol 22, 78-83, Copyright © 1993 by American Heart Association


ARTICLES

Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta

D Henrion and I Laher
Department of Pharmacology, University of Vermont, College of Medicine, Burlington 05405-0068.

Subthreshold concentrations of endothelin-1 potentiated the norepinephrine-induced contraction in isometrically mounted rings of the rabbit aorta. Pretreatment with endothelin-1 (0.1 nM) for 10 minutes increased the sensitivity of the aortic rings to norepinephrine without affecting the maximal contraction. This amplification was unaffected by removal of the endothelium but was prevented by the protein kinase C inhibitors staurosporine (0.01 microM) and calphostin C (0.1 microM). Pretreatment of the aortic rings for 24 hours with phorbol 12-myristate 13-acetate (0.1 microM) also abolished the potentiation. Norepinephrine-induced contraction was potentiated by pretreating with phorbol 12-myristate 13-acetate (10 nM) and by increasing the concentration of K+ in the bath solution from 4.6 to 8.6 mM. The potentiation of the norepinephrine-induced contraction by endothelin-1 (0.1 nM) or by phorbol 12-myristate 13-acetate (10 nM) was not associated with an increase in norepinephrine-induced 45Ca2+ uptake or influx, whereas the potentiation due to an increase in the concentration of K+ in the bath solution from 4.6 to 8.6 mM was associated with an increase in norepinephrine-induced 45Ca2+ uptake. We conclude that endothelin-1 potentiation of the norepinephrine-induced contraction occurs in the absence of changes in stimulated Ca2+ entry and is endothelium independent. It is probable that endothelin-1 increases the sensitivity of the contractile apparatus to Ca2+ by activating protein kinase C-dependent mechanisms.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. M. Kirshbom, W. T. Mahle, R. W. Joyner, T. Leong, M. Wilson, B. E. Kogon, K. R. Kanter, and M. M. Bouzyk
The endothelin-1 G5665T polymorphism impacts transplant-free survival for single ventricle patients
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Backs, E. Bresch, M. Lutz, A. V. Kristen, and M. Haass
Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats
Cardiovasc Res, August 1, 2005; 67(2): 283 - 290.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Gardner, T. C. Westfall, and H. Macarthur
Endothelin (ET)-1-Induced Inhibition of ATP Release from PC-12 Cells Is Mediated by the ETB Receptor: Differential Response to ET-1 on ATP, Neuropeptide Y, and Dopamine Levels
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1109 - 1117.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. J. Wingard, S. Husain, J. Williams, and S. James
RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1145 - R1152.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Hoang, H. Macarthur, A. Gardner, and T. C. Westfall
Endothelin-induced modulation of neuropeptide Y and norepinephrine release from the rat mesenteric bed
Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1523 - H1530.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Iglarz, J. Benessiano, I. Philip, S. Vuillaumier-Barrot, S. Lasocki, U. Hvass, G. Durand, J.-M. Desmonts, B. I. Levy, and D. Henrion
Preproendothelin-1 Gene Polymorphism Is Related to a Change in Vascular Reactivity in the Human Mammary Artery In Vitro
Hypertension, February 1, 2002; 39(2): 209 - 213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Y. Pang, H. Xu, N. Huang, C. R. Forrest, T. M. Perreault, and P. C. Neligan
Amplification effect and mechanism of action of ET-1 in U-46619-induced vasoconstriction in pig skin
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R713 - R720.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Takamura, R. Parent, P. Cernacek, and M. Lavallee
Influence of dual ETA/ETB-receptor blockade on coronary responses to treadmill exercise in dogs
J Appl Physiol, November 1, 2000; 89(5): 2041 - 2048.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Winegrad, D. Henrion, L. Rappaport, and J. L. Samuel
Self-Protection by Cardiac Myocytes Against Hypoxia and Hyperoxia
Circ. Res., October 15, 1999; 85(8): 690 - 698.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. Henrion, J. Benessiano, I. Philip, S. Vuillaumier-Barrot, M. Iglarz, G. Plantefeve, D. Chatel, U. Hvass, G. Durand, J.-M. Desmonts, et al.
The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 830 - 836.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. E. Sullivan, C. S. Thompson, M. R. Dashwood, M. A. Khan, J. Y. Jeremy, R. J. Morgan, and D. P. Mikhailidis
Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease?
Cardiovasc Res, August 15, 1999; 43(3): 658 - 665.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.-D. Nguyen, P. Vequaud, and E. Thorin
Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and {alpha}-adrenergic-dependent contractions of rabbit resistance arteries
Cardiovasc Res, August 15, 1999; 43(3): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Gondré and G. J. Christ
Endothelin-1-Induced Alterations in Phenylephrine-Induced Contractile Responses Are Largely Additive in Physiologically Diverse Rabbit Vasculature
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 635 - 642.
[Abstract] [Full Text]


Home page
HypertensionHome page
E. Thorin, P. Cernacek, and J. Dupuis
Endothelin-1 Regulates Tone of Isolated Small Arteries in the Rat : Effect of Hyperendothelinemia
Hypertension, April 1, 1998; 31(4): 1035 - 1041.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Thorin, S. M. Shreeve, N. Thorin-Trescases, and J. A. Bevan
Reversal of Endothelin-1 Release by Stimulation of Endothelial {alpha}2-Adrenoceptor Contributes to Cerebral Vasorelaxation
Hypertension, October 1, 1997; 30(4): 830 - 836.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. Rajagopalan, J. B. Laursen, A. Borthayre, S. Kurz, J. Keiser, S. Haleen, A. Giaid, and D. G. Harrison
\E Role for Endothelin-1 in Angiotensin II– Mediated Hypertension
Hypertension, July 1, 1997; 30(1): 29 - 34.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
A. O. A. Zschauer, M. W. Sielczak, D. A. S. Smith, and A. Wanner
Norepinephrine-induced contraction of isolated rabbit bronchial artery: role of alpha 1- and alpha 2-adrenoceptor activation
J Appl Physiol, June 1, 1997; 82(6): 1918 - 1925.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Henrion, F. J. Dowell, B. I. Levy, and J.-B. Michel
In Vitro Alteration of Aortic Vascular Reactivity in Hypertension Induced by Chronic NG-Nitro-L-Arginine Methyl Ester
Hypertension, September 1, 1996; 28(3): 361 - 366.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. A. H. Kaasjager, H. A. Koomans, and T. J. Rabelink
Effectiveness of Enalapril Versus Nifedipine to Antagonize Blood Pressure and the Renal Response to Endothelin in Humans
Hypertension, April 1, 1995; 25(4): 620 - 625.
[Abstract] [Full Text]